Pharmaceuticalization of Obesity: Empirical Analysis of Metro and Nonmetro Populations, Cognitions and Behavior
RB 5_22 Pharmaceuticalization of Obesity: Empirical Analysis of Metro and [...]
RB 5_22 Pharmaceuticalization of Obesity: Empirical Analysis of Metro and [...]
RB5_21 Beliefs about Dementia and Risk-Reducing Behavior: An Empirical Analysis [...]
RB5_20 Cognitive Functioning in Later-Life, Older than 65 Years: Insights [...]
RB 5-19 The Costs and Benefits of Recreational Cannabis Legalization [...]
RB 5-18 Theories of Financial Hardship and Measures of the [...]
RB 5-17 An Empirical Analysis of Financial Hardship Associated with [...]
RB 5-16 Burden of Health Care Costs for Persons with [...]
RB 5_15 Exploring the Other Side of Alzheimer’s Disease and [...]
RB 5-14 Urban-Rural Differences in Mental Health Concerns: Findings from [...]
RB5-13 Telemedicine and the Carbon Footprint of Healthcare: An Empirical [...]